Under the policy, blood-based tests may be eligible for coverage if they either are cleared or approved by the US FDA or measure phosphorylated-tau 217.

Jessica is a former writer and editor at Forbes Health with over a decade of experience in both lifestyle and clinical health topics. Before Forbes Health, Jessica was an editor for Healthline Media, ...

Using ChatGPT to audit my complex health insurance claims was a massive undertaking -- but it confirmed a hidden $1,512 ...

At Automate, Novarc highlighted the company’s NovAI Autonomy solution on the Yaskawa YRC1000 robot, featuring how the ...

CMS has spent the past three years systematically expanding colorectal cancer screening coverage — adding new modalities, eliminating patient cost-sharing and lowering the eligible age. For ...

Changes will go into effect Jan. 1, 2027, and aim to improve care delivery and data for maternal health outcomes.